ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000237773.1	Ponatinib	Thyroid carcinoma	0.032136974	Resistant
ENSG00000237773.1	Ponatinib	Bladder urothelial carcinoma	0.003333124	Sensitive